108 related articles for article (PubMed ID: 16891876)
1. Urethral stone formation after permanent radioactive seed implant for prostate cancer.
Steinmetz R; Barrett W
Am J Clin Oncol; 2006 Aug; 29(4):424-5. PubMed ID: 16891876
[No Abstract] [Full Text] [Related]
2. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging.
Sloboda RS; Usmani N; Pedersen J; Murtha A; Pervez N; Yee D
Brachytherapy; 2010; 9(4):354-61. PubMed ID: 20116344
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150.
Vordermark D; Noe M; Markert K; Wulf J; Müller G; Bratengeier K; Beckmann G; Baier F; Guckenberger M; Schiefelbein F; Schön G; Flentje M; Baier K
Radiother Oncol; 2009 May; 91(2):217-24. PubMed ID: 19136175
[TBL] [Abstract][Full Text] [Related]
4. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
[TBL] [Abstract][Full Text] [Related]
5. Radioactive seed implantation for prostate cancer.
Tecnologica; 1995 Oct; ():8-9. PubMed ID: 10168303
[No Abstract] [Full Text] [Related]
6. Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer.
Huyghe E; Delannes M; Wagner F; Delaunay B; Nohra J; Thoulouzan M; Shut-Yee JY; Plante P; Soulie M; Thonneau P; Bachaud JM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):126-32. PubMed ID: 19362236
[TBL] [Abstract][Full Text] [Related]
7. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
[TBL] [Abstract][Full Text] [Related]
8. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
Tanaka N; Asakawa I; Kondo H; Tanaka M; Fujimoto K; Hasegawa M; Konishi N; Hirao Y
Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
[TBL] [Abstract][Full Text] [Related]
9. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
[TBL] [Abstract][Full Text] [Related]
10. Radioactive prostatic implants: a potential autopsy hazard.
Start RD; Tindale W; Singleton M; Conway M; Richardson C
Histopathology; 2007 Aug; 51(2):246-8. PubMed ID: 17650218
[No Abstract] [Full Text] [Related]
11. [The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity].
Pommier P; Delannes M; LeFloch O; Bernier V; Baron MH; Thomas L; Malet C; Bonnet J; Louisot P; Aletti P; Goubard O; Chemin A; Chirat F; Lebivic S; Montbarbon X; Bachaud JM; Votron L; Lasbareilles O; Desmettre O; Bringeon G; Gassa F; Peiffert D
Cancer Radiother; 2006 Dec; 10(8):559-64. PubMed ID: 16959520
[TBL] [Abstract][Full Text] [Related]
12. Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.
Okaneya T; Nishizawa S; Nakayama T; Kamigaito T; Hashida I; Hosaka N
Int J Urol; 2007 Jul; 14(7):602-6. PubMed ID: 17645602
[TBL] [Abstract][Full Text] [Related]
13. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.
Mitchell DM; Swindell R; Elliott T; Wylie JP; Taylor CM; Logue JP
Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022
[TBL] [Abstract][Full Text] [Related]
14. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.
Ishiyama H; Satoh T; Kitano M; Tsumura H; Kotani S; Okusa H; Uemae M; Baba S; Hayakawa K
Jpn J Clin Oncol; 2008 Jul; 38(7):469-73. PubMed ID: 18577509
[TBL] [Abstract][Full Text] [Related]
15. Radioactive "seed" implants may rival surgery for low-risk prostate cancer patients.
Hede K
J Natl Cancer Inst; 2007 Oct; 99(20):1507-9. PubMed ID: 17925531
[No Abstract] [Full Text] [Related]
16. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
17. Variations in international prostate symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.
Tanaka N; Fujimoto K; Hirao Y; Asakawa I; Hasegawa M; Konishi N
Urology; 2009 Aug; 74(2):407-11. PubMed ID: 19376570
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.
Pinkawa M; Asadpour B; Piroth MD; Gagel B; Nussen S; Kehl M; Borchers H; Jakse G; Eble MJ
Radiother Oncol; 2009 May; 91(2):225-31. PubMed ID: 19081154
[TBL] [Abstract][Full Text] [Related]
19. Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds.
Bottomley D; Ash D; Al-Qaisieh B; Carey B; Joseph J; St Clair S; Gould K
Radiother Oncol; 2007 Jan; 82(1):46-9. PubMed ID: 17161481
[TBL] [Abstract][Full Text] [Related]
20. A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy.
Heysek RV; Gwede CK; Torres-Roca J; Cantor A; Kelley S; Saini AS; Pow-Sang J
Brachytherapy; 2006; 5(4):244-50. PubMed ID: 17118318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
